Cuba vs Liberia: The number of people with susceptibility test result for rifampicin
Cuba
40.43
in 2021
Liberia
37.16
in 2021
Cuba rank
124th
Liberia rank
126th
The number of people with susceptibility test result for rifampicin over time
- Cuba
- Liberia
How they compare
Cuba currently reports 40.43 against 37.16 in Liberia, a difference of 3.27.
That makes Cuba's figure about 1.1 times Liberia's.
Across all 5 years both countries report, Cuba has been ahead every year.
Cuba ranks 124th and Liberia ranks 126th of 146 countries.
Cuba has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cuba | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.38 | 35.42 | 30.97 | Cuba |
| 2020s | 45.55 | 30.78 | 14.77 | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cuba or Liberia?
- Cuba, at 40.43 against 37.16 in Liberia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cuba and Liberia?
- 3.27, with Cuba ahead.
- How many years of comparable data are there for Cuba and Liberia?
- 5 years are reported by both, from 2017 to 2021.
- How do Cuba and Liberia rank globally for the number of people with susceptibility test result for rifampicin?
- Cuba ranks 124th and Liberia ranks 126th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.